Finished
Development of an Exoskeleton for Patients' Mobility.
NCT06513390 · Vidyasirimedhi Institute of Science & Technology (VISTEC) · Updated 22 July 2024
- What is being tested
- Exoskeleton of default mode; Exoskeleton of Intelligent mode
- For
- Healthy
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 60 years. About 8 people. The full rules are on the registry page.
- Where
- Thailand
- When
- Starts or started 1 July 2022, ends 12 July 2022. Registered 22 July 2024.
- Results
- None posted yet.
In the researchers' words
The goal of this clinical trial is to investigate the performance of a state-of-the-art adaptive CPG-based exoskeleton control system (intelligent mode) under a multi-metric analysis (involving three-dimensional gait analysis, muscle activity, oxygen consumption, user comfort, and exoskeleton performance scores) and comparing it to a standard commercial exoskeleton control system (default mode) The main question it aims to answer is: Could the adaptive version improve natural walking and essential lower limb motions? Participants will: All participants were assigned into two groups to receive an alternate sequence of walking with the intelligent mode or the default mode of the lower-limb exoskeleton Exo-H3 at high and normal speed.
Sites
- Faculty of Medicine Ramathibodi Hospital, Mahidol UniversityBangkok, Thailand